| Original language | English (US) |
|---|---|
| Pages (from-to) | 1022-1023 |
| Number of pages | 2 |
| Journal | The Lancet Oncology |
| Volume | 17 |
| Issue number | 8 |
| DOIs |
|
| State | Published - Aug 1 2016 |
Fingerprint
Osteosarcoma
ASJC Scopus subject areas
- Oncology
Cite this
Janeway, K. A., & Gorlick, R. (2016). The case for informative phase 2 trials in osteosarcoma. The Lancet Oncology, 17(8), 1022-1023. https://doi.org/10.1016/S1470-2045(16)30293-5
The case for informative phase 2 trials in osteosarcoma. / Janeway, Katherine A.; Gorlick, Richard.
In: The Lancet Oncology, Vol. 17, No. 8, 01.08.2016, p. 1022-1023.Research output: Contribution to journal › Comment/debate
Janeway, KA & Gorlick, R 2016, 'The case for informative phase 2 trials in osteosarcoma', The Lancet Oncology, vol. 17, no. 8, pp. 1022-1023. https://doi.org/10.1016/S1470-2045(16)30293-5
Janeway KA, Gorlick R. The case for informative phase 2 trials in osteosarcoma. The Lancet Oncology. 2016 Aug 1;17(8):1022-1023. https://doi.org/10.1016/S1470-2045(16)30293-5
@article{d9f298ef72ee40b9a73bcd42631f2a8e,
title = "The case for informative phase 2 trials in osteosarcoma",
author = "Janeway, {Katherine A.} and Richard Gorlick",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/S1470-2045(16)30293-5",
language = "English (US)",
volume = "17",
pages = "1022--1023",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "8",
}
TY - JOUR
T1 - The case for informative phase 2 trials in osteosarcoma
AU - Janeway, Katherine A.
AU - Gorlick, Richard
PY - 2016/8/1
Y1 - 2016/8/1
UR - http://www.scopus.com/inward/record.url?scp=84995933315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995933315&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(16)30293-5
DO - 10.1016/S1470-2045(16)30293-5
M3 - Comment/debate
VL - 17
SP - 1022
EP - 1023
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 8
ER -